There are comparatively little data on the incidence and morbidity from pneumococcal
disease in Australia and elsewhere. Available data suggest that the overall incidence of …

Streptococcus pneumoniae causes acute bacterial infections. The bacterium, also called
pneumococcus, was first isolated by Louis Pasteur in 1881 from the saliva of a patient with …

The proceedings of the Pneumococcal Disease in Australia Workshop, held on 26-27 March
1999 are presented in this report. The world-wide epidemiology of the pneumococcus, with …

This report updates the last recommendations by the Advisory Committee on Immunization
Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989; 38: 64-8 …

Streptococcus pneumoniae is a major cause of morbidity and mortality in young children
throughout the world, causing both invasive (meningitis, bacteraemia) and non-invasive …

Pneumococcal disease is a major cause of illness and death in the young, the elderly, and
those with certain medical conditions. Pneumococcal conjugate vaccines are changing both …

Abstract Information on pneumococcal disease, including immunisation programs, and
optimum future surveillance in each Australian State and Territory were discussed at the …

This book describes the development of protein conjugate vaccines against pneumococcal
disease, their impact on respiratory and other pneumococcal infections, and the vaccines' …

Vaccination against pneumococci is one of the most effective methods of preventing
pneumococcal diseases. Currently, 10-and 13-valent conjugate vaccines (PCV10 and …

Pneumococcal pneumonia and bacteraemia are an important cause of morbidity and
mortality, especially in a number of risk groups. On the basis of data from available literature …